APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cilostazol

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cilostazol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchCilostazol Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Cilostazol Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cilostazol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cilostazol Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Cilostazol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Cilostazol market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cilostazol include Chongqing Pharscin pharmaceutical, Zhejiang Weikang Pharmaceutical, Abbott, Takeda, Teva, Novartis, Mylan, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cilostazol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cilostazol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cilostazol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cilostazol market size, projected growth trends, production technologies, key applications, and end-use industries.

Cilostazol Segment by Company

Chongqing Pharscin pharmaceutical

Zhejiang Weikang Pharmaceutical

Abbott

Takeda

Teva

Novartis

Mylan

Pfizer

GSK

Chengdu Leer Pharmaceutical

Yantai Yisheng Pharmaceutical

Squibb

Sandoz

Otsuka Pharmaceutical

Mayne Pharma

Hikma Pharmaceuticals

Cadila Pharmaceuticals

Bedford Laboratories

Cilostazol Segment by Type

Injection Cilostazol

Oral Cilostazol

Freeze-dried Powder Cilostazol

Cilostazol Segment by Application

Hospital

Clinic

Others

Cilostazol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cilostazol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cilostazol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cilostazol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cilostazol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cilostazol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cilostazol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cilostazol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cilostazol Industry Trends Table 2. Cilostazol Industry Drivers Table 3. Cilostazol Industry Opportunities and Challenges Table 4. Cilostazol Industry Restraints Table 5. Global Cilostazol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cilostazol Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cilostazol Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cilostazol Sales Market Share by Manufacturers Table 9. Global Cilostazol Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cilostazol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cilostazol Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cilostazol Manufacturers, Product Type & Application Table 13. Global Cilostazol Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cilostazol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Cilostazol Table 17. Major Manufacturers of Oral Cilostazol Table 18. Major Manufacturers of Freeze-dried Powder Cilostazol Table 19. Global Cilostazol Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Cilostazol Sales by Type (2021-2026) & (K Units) Table 21. Global Cilostazol Sales by Type (2027-2032) & (K Units) Table 22. Global Cilostazol Sales Market Share by Type (2021-2026) Table 23. Global Cilostazol Sales Market Share by Type (2027-2032) Table 24. Global Cilostazol Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Cilostazol Revenue by Type (2021-2026) & (K Units) Table 26. Global Cilostazol Revenue by Type (2027-2032) & (K Units) Table 27. Global Cilostazol Revenue Market Share by Type (2021-2026) Table 28. Global Cilostazol Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Others Table 32. Global Cilostazol Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Cilostazol Sales by Application (2021-2026) & (K Units) Table 34. Global Cilostazol Sales by Application (2027-2032) & (K Units) Table 35. Global Cilostazol Sales Market Share by Application (2021-2026) Table 36. Global Cilostazol Sales Market Share by Application (2027-2032) Table 37. Global Cilostazol Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Cilostazol Revenue by Application (2021-2026) & (K Units) Table 39. Global Cilostazol Revenue by Application (2027-2032) & (K Units) Table 40. Global Cilostazol Revenue Market Share by Application (2021-2026) Table 41. Global Cilostazol Revenue Market Share by Application (2027-2032) Table 42. Global Cilostazol Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Cilostazol Sales by Region (2021-2026) & (K Units) Table 44. Global Cilostazol Sales Market Share by Region (2021-2026) Table 45. Global Cilostazol Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Cilostazol Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Cilostazol Sales by Country (2021-2026) & (K Units) Table 49. North America Cilostazol Sales by Country (2027-2032) & (K Units) Table 50. Europe Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Cilostazol Sales by Country (2021-2026) & (K Units) Table 52. Europe Cilostazol Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Cilostazol Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Cilostazol Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Cilostazol Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Cilostazol Sales by Country (2027-2032) & (K Units) Table 59. Global Cilostazol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Cilostazol Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Cilostazol Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Cilostazol Revenue Market Share by Region (2021-2026) Table 63. Global Cilostazol Revenue Market Share by Region (2027-2032) Table 64. Chongqing Pharscin pharmaceutical Company Information Table 65. Chongqing Pharscin pharmaceutical Business Overview Table 66. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio Table 68. Chongqing Pharscin pharmaceutical Recent Development Table 69. Zhejiang Weikang Pharmaceutical Company Information Table 70. Zhejiang Weikang Pharmaceutical Business Overview Table 71. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio Table 73. Zhejiang Weikang Pharmaceutical Recent Development Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Abbott Cilostazol Product Portfolio Table 78. Abbott Recent Development Table 79. Takeda Company Information Table 80. Takeda Business Overview Table 81. Takeda Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Takeda Cilostazol Product Portfolio Table 83. Takeda Recent Development Table 84. Teva Company Information Table 85. Teva Business Overview Table 86. Teva Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Teva Cilostazol Product Portfolio Table 88. Teva Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis Cilostazol Product Portfolio Table 93. Novartis Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mylan Cilostazol Product Portfolio Table 98. Mylan Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Cilostazol Product Portfolio Table 103. Pfizer Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. GSK Cilostazol Product Portfolio Table 108. GSK Recent Development Table 109. Chengdu Leer Pharmaceutical Company Information Table 110. Chengdu Leer Pharmaceutical Business Overview Table 111. Chengdu Leer Pharmaceutical Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Chengdu Leer Pharmaceutical Cilostazol Product Portfolio Table 113. Chengdu Leer Pharmaceutical Recent Development Table 114. Yantai Yisheng Pharmaceutical Company Information Table 115. Yantai Yisheng Pharmaceutical Business Overview Table 116. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio Table 118. Yantai Yisheng Pharmaceutical Recent Development Table 119. Squibb Company Information Table 120. Squibb Business Overview Table 121. Squibb Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Squibb Cilostazol Product Portfolio Table 123. Squibb Recent Development Table 124. Sandoz Company Information Table 125. Sandoz Business Overview Table 126. Sandoz Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sandoz Cilostazol Product Portfolio Table 128. Sandoz Recent Development Table 129. Otsuka Pharmaceutical Company Information Table 130. Otsuka Pharmaceutical Business Overview Table 131. Otsuka Pharmaceutical Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Otsuka Pharmaceutical Cilostazol Product Portfolio Table 133. Otsuka Pharmaceutical Recent Development Table 134. Mayne Pharma Company Information Table 135. Mayne Pharma Business Overview Table 136. Mayne Pharma Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Mayne Pharma Cilostazol Product Portfolio Table 138. Mayne Pharma Recent Development Table 139. Hikma Pharmaceuticals Company Information Table 140. Hikma Pharmaceuticals Business Overview Table 141. Hikma Pharmaceuticals Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Hikma Pharmaceuticals Cilostazol Product Portfolio Table 143. Hikma Pharmaceuticals Recent Development Table 144. Cadila Pharmaceuticals Company Information Table 145. Cadila Pharmaceuticals Business Overview Table 146. Cadila Pharmaceuticals Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Cadila Pharmaceuticals Cilostazol Product Portfolio Table 148. Cadila Pharmaceuticals Recent Development Table 149. Bedford Laboratories Company Information Table 150. Bedford Laboratories Business Overview Table 151. Bedford Laboratories Cilostazol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Bedford Laboratories Cilostazol Product Portfolio Table 153. Bedford Laboratories Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Cilostazol Distributors List Table 157. Cilostazol Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Cilostazol Product Image Figure 2. Global Cilostazol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cilostazol Market Size (2021-2032) & (US$ Million) Figure 4. Global Cilostazol Sales (2021-2032) & (K Units) Figure 5. Global Cilostazol Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cilostazol Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Cilostazol Image Figure 9. Oral Cilostazol Image Figure 10. Freeze-dried Powder Cilostazol Image Figure 11. Global Cilostazol Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Cilostazol Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cilostazol Sales Market Share by Type (2021-2032) Figure 14. Global Cilostazol Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Cilostazol Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Cilostazol Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Cilostazol Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Cilostazol Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cilostazol Sales Market Share by Application (2021-2032) Figure 23. Global Cilostazol Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Cilostazol Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cilostazol Revenue Market Share by Application (2021-2032) Figure 26. North America Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Cilostazol Sales Market Share by Country (2021-2032) Figure 28. U.S. Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Cilostazol Sales Market Share by Country (2021-2032) Figure 33. Germany Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Cilostazol Sales Market Share by Country (2021-2032) Figure 40. China Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Cilostazol Sales Market Share by Country (2021-2032) Figure 48. Brazil Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Cilostazol Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Cilostazol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Cilostazol Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Cilostazol Revenue (2021-2032) & (US$ Million) Figure 59. North America Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Cilostazol Revenue (2021-2032) & (US$ Million) Figure 61. Europe Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Cilostazol Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Cilostazol Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Cilostazol Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cilostazol Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Cilostazol
  • Oral Cilostazol
  • Freeze-dried Powder Cilostazol
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chongqing Pharscin pharmaceutical
  • Zhejiang Weikang Pharmaceutical
  • Abbott
  • Takeda
  • Teva
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Chengdu Leer Pharmaceutical
  • Yantai Yisheng Pharmaceutical
  • Squibb
  • Sandoz
  • Otsuka Pharmaceutical
  • Mayne Pharma
  • Hikma Pharmaceuticals
  • Cadila Pharmaceuticals
  • Bedford Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cilostazol Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cilostazol Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cilostazol Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cilostazol Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cilostazol Market Dynamics
  1. 2.1 Cilostazol Industry Trends
  2. 2.2 Cilostazol Industry Drivers
  3. 2.3 Cilostazol Industry Opportunities and Challenges
  4. 2.4 Cilostazol Industry Restraints
3 Cilostazol Market by Manufacturers
  1. 3.1 Global Cilostazol Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cilostazol Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cilostazol Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cilostazol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cilostazol Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cilostazol Manufacturers, Product Type & Application
  7. 3.7 Global Cilostazol Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cilostazol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cilostazol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cilostazol Tier 1, Tier 2, and Tier 3
4 Cilostazol Market by Type
  1. 4.1 Cilostazol Type Introduction
  2. 4.1.1 Injection Cilostazol
  3. 4.1.2 Oral Cilostazol
  4. 4.1.3 Freeze-dried Powder Cilostazol
  5. 4.2 Global Cilostazol Sales by Type
  6. 4.2.1 Global Cilostazol Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cilostazol Sales by Type (2021-2032)
  8. 4.2.3 Global Cilostazol Sales Market Share by Type (2021-2032)
  9. 4.3 Global Cilostazol Revenue by Type
  10. 4.3.1 Global Cilostazol Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cilostazol Revenue by Type (2021-2032)
  12. 4.3.3 Global Cilostazol Revenue Market Share by Type (2021-2032)
5 Cilostazol Market by Application
  1. 5.1 Cilostazol Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cilostazol Sales by Application
  6. 5.2.1 Global Cilostazol Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cilostazol Sales by Application (2021-2032)
  8. 5.2.3 Global Cilostazol Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cilostazol Revenue by Application
  10. 5.3.1 Global Cilostazol Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cilostazol Revenue by Application (2021-2032)
  12. 5.3.3 Global Cilostazol Revenue Market Share by Application (2021-2032)
6 Global Cilostazol Sales by Region
  1. 6.1 Global Cilostazol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cilostazol Sales by Region (2021-2032)
  3. 6.2.1 Global Cilostazol Sales by Region (2021-2026)
  4. 6.2.2 Global Cilostazol Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cilostazol Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cilostazol Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cilostazol Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cilostazol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cilostazol Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cilostazol Revenue by Region
  1. 7.1 Global Cilostazol Revenue by Region
  2. 7.1.1 Global Cilostazol Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cilostazol Revenue by Region (2021-2026)
  4. 7.1.3 Global Cilostazol Revenue by Region (2027-2032)
  5. 7.1.4 Global Cilostazol Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cilostazol Revenue (2021-2032)
  8. 7.2.2 North America Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cilostazol Revenue (2021-2032)
  11. 7.3.2 Europe Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cilostazol Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cilostazol Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cilostazol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Pharscin pharmaceutical
  2. 8.1.1 Chongqing Pharscin pharmaceutical Company Information
  3. 8.1.2 Chongqing Pharscin pharmaceutical Business Overview
  4. 8.1.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio
  6. 8.1.5 Chongqing Pharscin pharmaceutical Recent Developments
  7. 8.2 Zhejiang Weikang Pharmaceutical
  8. 8.2.1 Zhejiang Weikang Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Weikang Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio
  12. 8.2.5 Zhejiang Weikang Pharmaceutical Recent Developments
  13. 8.3 Abbott
  14. 8.3.1 Abbott Company Information
  15. 8.3.2 Abbott Business Overview
  16. 8.3.3 Abbott Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Cilostazol Product Portfolio
  18. 8.3.5 Abbott Recent Developments
  19. 8.4 Takeda
  20. 8.4.1 Takeda Company Information
  21. 8.4.2 Takeda Business Overview
  22. 8.4.3 Takeda Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takeda Cilostazol Product Portfolio
  24. 8.4.5 Takeda Recent Developments
  25. 8.5 Teva
  26. 8.5.1 Teva Company Information
  27. 8.5.2 Teva Business Overview
  28. 8.5.3 Teva Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Cilostazol Product Portfolio
  30. 8.5.5 Teva Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Cilostazol Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Cilostazol Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Cilostazol Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 GSK
  50. 8.9.1 GSK Company Information
  51. 8.9.2 GSK Business Overview
  52. 8.9.3 GSK Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GSK Cilostazol Product Portfolio
  54. 8.9.5 GSK Recent Developments
  55. 8.10 Chengdu Leer Pharmaceutical
  56. 8.10.1 Chengdu Leer Pharmaceutical Company Information
  57. 8.10.2 Chengdu Leer Pharmaceutical Business Overview
  58. 8.10.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Leer Pharmaceutical Cilostazol Product Portfolio
  60. 8.10.5 Chengdu Leer Pharmaceutical Recent Developments
  61. 8.11 Yantai Yisheng Pharmaceutical
  62. 8.11.1 Yantai Yisheng Pharmaceutical Company Information
  63. 8.11.2 Yantai Yisheng Pharmaceutical Business Overview
  64. 8.11.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio
  66. 8.11.5 Yantai Yisheng Pharmaceutical Recent Developments
  67. 8.12 Squibb
  68. 8.12.1 Squibb Company Information
  69. 8.12.2 Squibb Business Overview
  70. 8.12.3 Squibb Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Squibb Cilostazol Product Portfolio
  72. 8.12.5 Squibb Recent Developments
  73. 8.13 Sandoz
  74. 8.13.1 Sandoz Company Information
  75. 8.13.2 Sandoz Business Overview
  76. 8.13.3 Sandoz Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sandoz Cilostazol Product Portfolio
  78. 8.13.5 Sandoz Recent Developments
  79. 8.14 Otsuka Pharmaceutical
  80. 8.14.1 Otsuka Pharmaceutical Company Information
  81. 8.14.2 Otsuka Pharmaceutical Business Overview
  82. 8.14.3 Otsuka Pharmaceutical Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Otsuka Pharmaceutical Cilostazol Product Portfolio
  84. 8.14.5 Otsuka Pharmaceutical Recent Developments
  85. 8.15 Mayne Pharma
  86. 8.15.1 Mayne Pharma Company Information
  87. 8.15.2 Mayne Pharma Business Overview
  88. 8.15.3 Mayne Pharma Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Mayne Pharma Cilostazol Product Portfolio
  90. 8.15.5 Mayne Pharma Recent Developments
  91. 8.16 Hikma Pharmaceuticals
  92. 8.16.1 Hikma Pharmaceuticals Company Information
  93. 8.16.2 Hikma Pharmaceuticals Business Overview
  94. 8.16.3 Hikma Pharmaceuticals Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hikma Pharmaceuticals Cilostazol Product Portfolio
  96. 8.16.5 Hikma Pharmaceuticals Recent Developments
  97. 8.17 Cadila Pharmaceuticals
  98. 8.17.1 Cadila Pharmaceuticals Company Information
  99. 8.17.2 Cadila Pharmaceuticals Business Overview
  100. 8.17.3 Cadila Pharmaceuticals Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cadila Pharmaceuticals Cilostazol Product Portfolio
  102. 8.17.5 Cadila Pharmaceuticals Recent Developments
  103. 8.18 Bedford Laboratories
  104. 8.18.1 Bedford Laboratories Company Information
  105. 8.18.2 Bedford Laboratories Business Overview
  106. 8.18.3 Bedford Laboratories Cilostazol Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bedford Laboratories Cilostazol Product Portfolio
  108. 8.18.5 Bedford Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cilostazol Value Chain Analysis
  2. 9.1.1 Cilostazol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cilostazol Production Mode & Process
  6. 9.2 Cilostazol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cilostazol Distributors
  9. 9.2.3 Cilostazol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst